
Annexon Inc.
Corporate Presentation - March 2025
CORPORATE PRESENTATION | MARCH 2025 Nasdaq: ANNX 1 A bold mission to enable MILLIONS of PATIENTS impacted by complement- mediated diseases of the body, brain and eye LIVE THEIR BEST LIVES 3 BREAKTHROUGH 2025: Annexon Well-Positioned to Transform the Complement Landscape and Drive Immense Value Clinically Validated Scientific Platform with broad potential across multiple therap ...